Waters Corporation (Massachusetts, USA) has announced the addition of the Colorado State University Fort Collins Proteomics and Metabolomics facility to its Centers of Innovation Programme. Directed by Dr Jessica Prenni, the facility is focused on the application of non-targeted proteomics and metOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.